DK464483D0 - Fremgangsmade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel - Google Patents
Fremgangsmade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middelInfo
- Publication number
- DK464483D0 DK464483D0 DK4644/83A DK464483A DK464483D0 DK 464483 D0 DK464483 D0 DK 464483D0 DK 4644/83 A DK4644/83 A DK 4644/83A DK 464483 A DK464483 A DK 464483A DK 464483 D0 DK464483 D0 DK 464483D0
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- procedure
- fibrinolytic agent
- pharmaceutical preparation
- pharmaceutical
- Prior art date
Links
- 239000003527 fibrinolytic agent Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 206010061216 Infarction Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 230000007574 infarction Effects 0.000 abstract 1
- 210000004165 myocardium Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A61K38/166—Streptokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT49241/82A IT1189379B (it) | 1982-10-08 | 1982-10-08 | Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico |
IT4924182 | 1982-10-08 |
Publications (4)
Publication Number | Publication Date |
---|---|
DK464483D0 true DK464483D0 (da) | 1983-10-07 |
DK464483A DK464483A (da) | 1984-04-09 |
DK161564B DK161564B (da) | 1991-07-22 |
DK161564C DK161564C (da) | 1992-01-06 |
Family
ID=11270058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK464483A DK161564C (da) | 1982-10-08 | 1983-10-07 | Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase |
Country Status (12)
Country | Link |
---|---|
US (1) | US4568543A (da) |
EP (1) | EP0106812B1 (da) |
JP (1) | JPS5989630A (da) |
AT (1) | ATE44467T1 (da) |
AU (1) | AU559192B2 (da) |
CA (1) | CA1217717A (da) |
DE (2) | DE106812T1 (da) |
DK (1) | DK161564C (da) |
ES (1) | ES8704736A1 (da) |
IL (1) | IL69938A (da) |
IT (1) | IT1189379B (da) |
ZA (1) | ZA837484B (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5275812A (en) * | 1985-06-07 | 1994-01-04 | The General Hospital Corporation | Method of treatment for myocardial infarction |
US5279824A (en) * | 1988-04-14 | 1994-01-18 | Merck Patent Gmbh | Pharmaceutical formulation containing heparin and endo-beta-glucuronidase, useful for the treatment of thrombosis |
DE69019141T2 (de) * | 1989-01-27 | 1996-01-18 | Immunolytics Inc | Zusammensetzung und verfahren für die behandlung gutartiger prostata-hypertrophie. |
CA2027936C (en) | 1989-10-23 | 2001-07-24 | Smithkline Beecham Corporation | Cyclic anti-aggregatory peptides |
US5939412A (en) * | 1992-06-26 | 1999-08-17 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
JPH10511356A (ja) * | 1994-12-22 | 1998-11-04 | スミスクライン・ビーチャム・コーポレイション | フィブリノゲン受容体拮抗物質 |
EP1521523A4 (en) * | 2002-05-20 | 2006-04-19 | Univ Texas | METHODS AND COMPOSITIONS FOR DELIVERING NUCLEIC ACID ENZYMES AND MOLECULES IN BRAIN, BONE, AND OTHER FABRICS |
US7220407B2 (en) * | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1179787A (en) * | 1967-03-22 | 1970-01-28 | Biorex Laboratories Ltd | Stabilised and Potentiated Therapeutic Enzyme Compositions |
US3708575A (en) * | 1970-05-13 | 1973-01-02 | Biorex Laboratories Ltd | Method for the treatment of atherosclerosis employing glucuronoglycos-aminoglycan-hyaluronate-lyase |
US4271150A (en) * | 1979-03-07 | 1981-06-02 | Zeria-Shinyaku Kogyo Kabushiki Kaisha | Urokinase preparation for oral administration |
-
1982
- 1982-10-08 IT IT49241/82A patent/IT1189379B/it active
-
1983
- 1983-10-05 EP EP83830192A patent/EP0106812B1/en not_active Expired
- 1983-10-05 DE DE198383830192T patent/DE106812T1/de active Pending
- 1983-10-05 DE DE8383830192T patent/DE3380166D1/de not_active Expired
- 1983-10-05 AU AU19883/83A patent/AU559192B2/en not_active Expired
- 1983-10-05 AT AT83830192T patent/ATE44467T1/de not_active IP Right Cessation
- 1983-10-06 ES ES526300A patent/ES8704736A1/es not_active Expired
- 1983-10-06 ZA ZA837484A patent/ZA837484B/xx unknown
- 1983-10-07 CA CA000438588A patent/CA1217717A/en not_active Expired
- 1983-10-07 DK DK464483A patent/DK161564C/da not_active IP Right Cessation
- 1983-10-07 JP JP58187167A patent/JPS5989630A/ja active Granted
- 1983-10-09 IL IL69938A patent/IL69938A/xx not_active IP Right Cessation
-
1984
- 1984-11-08 US US06/669,462 patent/US4568543A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA1217717A (en) | 1987-02-10 |
JPS6150927B2 (da) | 1986-11-06 |
DE106812T1 (de) | 1984-08-30 |
IT1189379B (it) | 1988-02-04 |
ES526300A0 (es) | 1987-05-01 |
ES8704736A1 (es) | 1987-05-01 |
IL69938A0 (en) | 1984-01-31 |
EP0106812B1 (en) | 1989-07-12 |
AU1988383A (en) | 1984-04-12 |
DK161564B (da) | 1991-07-22 |
AU559192B2 (en) | 1987-02-26 |
ZA837484B (en) | 1984-06-27 |
DK464483A (da) | 1984-04-09 |
JPS5989630A (ja) | 1984-05-23 |
DK161564C (da) | 1992-01-06 |
IL69938A (en) | 1987-09-16 |
DE3380166D1 (en) | 1989-08-17 |
IT8249241A0 (it) | 1982-10-08 |
ATE44467T1 (de) | 1989-07-15 |
EP0106812A3 (en) | 1985-09-11 |
EP0106812A2 (en) | 1984-04-25 |
US4568543A (en) | 1986-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY101791A (en) | New benzimidazole derivatives | |
ATE22562T1 (de) | 6-substituierte s-triazolo(3,4-a)phthalazinderivate. | |
ES8206180A1 (es) | Un metodo para producir una composicion farmaceutica solida de un medicamento en microdosis. | |
LV5503A3 (lv) | Panemiens omeprazola salu iegusanai | |
MY8700761A (en) | Novel antihistamines process for their preparation and pharmaceutical compositions containing them | |
DE3271990D1 (en) | Therapeutically active compound and pharmaceutical composition containing the same | |
EG18379A (en) | Novel pharmacological compounds | |
DE69034226D1 (de) | Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu | |
MY108146A (en) | Medicaments for treating inflammatory conditions or for analgesia | |
DK464483D0 (da) | Fremgangsmade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel | |
ES8406439A1 (es) | Procedimiento de preparar compuestos 1,4-dihidropiridinicos. | |
ES8707488A1 (es) | Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona | |
FR2580649B1 (fr) | (-) - 1b - ethyl - 1a - hydroxymethyl -1,2,3,4,6,7,12,12ba-octahydroindolo(2,3-a) quinolizine, procede pour la preparer et compositions pharmaceutiques contenant celle-ci | |
ATE87482T1 (de) | Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen. | |
JPS53127832A (en) | Antiphkogistics for oral administration containing thiaprostaglandins | |
DE3484155D1 (de) | Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216. | |
ZA775472B (en) | Biologically active tetracyclic compounds and pharmaceutical compositions containing same | |
ES8304059A1 (es) | Procedimiento para la preparacion de composiciones a base desalicilato de imidazol | |
TR22867A (tr) | Birden fazla aktif bilesen ihtiva eden insektisid terkibi | |
IT1178218B (it) | Composti derivati dal fluorene ad attivita' antinfiammatoria, analgesica ed antipiretica e composizioni farmaceutiche che li contengono | |
ZA81615B (en) | Cytostatically active pharmaceutical preparations and the use of poly-glycidyl-substituted n-heterocyclic ring compounds in pharmaceutical preparations | |
JPS52130926A (en) | Medicinal composition comprising pentazocine and salicylamide | |
IT8321358A0 (it) | Derivati ad attivita' terapeutica della s-carbossimetilcisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
SE8704049D0 (sv) | Novel pharmacological compounds | |
ES8201133A1 (es) | Un procedimiento para la produccion de 1-(1-metiletil)amino-3-(4-alquiltio)-1-naftalenil-oxi-2-propanol. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |